As of the latest Form 4 filed Jun 16, 2026.
What Bausch + Lomb Corp insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 73 most recent filings for BLCO.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-16 | 2026-06-12 | Bonnefoy Luc President, Surgical | FTax | −1.01K | $15.08 | $15.2K | No | Form 4 ↗ |
| 2026-05-28 | 2026-05-26 | VON ESCHENBACH ANDREW C. Director | AAward | +15.8K | $15.78 | $250K | No | Form 4 ↗ |
| 2026-05-28 | 2026-05-26 | Ross Thomas W. Sr. Director | AAward | +15.8K | $15.78 | $250K | No | Form 4 ↗ |
| 2026-05-28 | 2026-05-26 | ROBERTSON RUSSEL C Director | AAward | +15.8K | $15.78 | $250K | No | Form 4 ↗ |
| 2026-05-28 | 2026-05-26 | Paulson John Director | AAward | +15.8K | $15.78 | $250K | No | Form 4 ↗ |
| 2026-05-28 | 2026-05-26 | Ling Karen Director | AAward | +15.8K | $15.78 | $250K | No | Form 4 ↗ |
| 2026-05-28 | 2026-05-26 | KAVANAGH SARAH B Director | AAward | +15.8K | $15.78 | $250K | No | Form 4 ↗ |
| 2026-05-28 | 2026-05-26 | COLLIS STEVEN H Director | AAward | +15.8K | $15.78 | $250K | No | Form 4 ↗ |
| 2026-05-28 | 2026-05-26 | Bernier Nathalie D. Director | AAward | +15.8K | $15.78 | $250K | No | Form 4 ↗ |
| 2026-05-28 | 2026-05-26 | Alfonso Eduardo Director | AAward | +15.8K | $15.78 | $250K | No | Form 4 ↗ |
| 2026-05-26 | 2026-05-22 | SAUNDERS BRENT L Chairman of the Board and CEO | FTax | −2.89K | $15.92 | $45.9K | No | Form 4 ↗ |
| 2026-05-07 | 2026-05-05 | Eldessouky Sam EVP and CFO | FTax | −63.9K | $16.00 | $1.02M | No | Form 4 ↗ |
| 2026-05-07 | 2026-05-05 | Hashad Yehia EVP of R&D and CMO | FTax | −13.7K | $16.00 | $219K | No | Form 4 ↗ |
| 2026-05-07 | 2026-05-05 | Munsch Frederick SVP, Controller and CAO | FTax | −8.67K | $16.00 | $139K | No | Form 4 ↗ |
| 2026-05-07 | 2026-05-05 | Bonnefoy Luc President, Surgical | FTax | −12.0K | $16.00 | $192K | No | Form 4 ↗ |
| 2026-05-01 | 2026-04-30 | ROBERTSON RUSSEL C Director | AAward | +1.61K | $15.90 | $25.6K | No | Form 4 ↗ |
| 2026-05-01 | 2026-04-30 | Paulson John Director | AAward | +1.38K | $15.90 | $21.9K | No | Form 4 ↗ |
| 2026-05-01 | 2026-04-30 | COLLIS STEVEN H Director | AAward | +1.42K | $15.90 | $22.5K | No | Form 4 ↗ |
| 2026-05-01 | 2026-04-30 | Alfonso Eduardo Director | AAward | +1.38K | $15.90 | $21.9K | No | Form 4 ↗ |
| 2026-04-27 | 2026-04-24 | Stewart Andrew J. President, GPIC | FTax | −4.22K | $15.82 | $66.7K | No | Form 4 ↗ |
| 2026-04-27 | 2026-04-24 | Bailey A Robert D EVP & Chief Legal Officer | FTax | −15.8K | $15.82 | $250K | No | Form 4 ↗ |
| 2026-03-10 | 2026-03-06 | Bailey A Robert D EVP & Chief Legal Officer | AAward | +14.6K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-10 | 2026-03-06 | Bailey A Robert D, EVP & Chief Legal Officer | PPurchase | +14.6K | $17.15 | $250K | No | Form 4 ↗ |
| 2026-03-10 | 2026-03-06 | Eldessouky Sam EVP and CFO | AAward | +4.00K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-10 | 2026-03-06 | Eldessouky Sam, EVP and CFO | PPurchase | +4.00K | $17.13 | $68.5K | No | Form 4 ↗ |
| 2026-03-10 | 2026-03-06 | SAUNDERS BRENT L CEO and Chairman of the Board | AAward | +14.7K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-10 | 2026-03-06 | SAUNDERS BRENT L, CEO and Chairman of the Board | PPurchase | +14.7K | $17.14 | $252K | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-03 | Ross Thomas W. Sr. Director | AAward | +4.50K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-04 | 2026-03-03 | Ross Thomas W. Sr., Director | PPurchase | +4.50K | $17.68 | $79.6K | No | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Alfonso Eduardo Director | AAward | +4.30K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Alfonso Eduardo, Director | PPurchase | +4.30K | $17.90 | $77.0K | No | Form 4 ↗ |
| 2026-03-03 | 2026-02-27 | VON ESCHENBACH ANDREW C. Director | AAward | +4.36K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-03 | 2026-02-27 | VON ESCHENBACH ANDREW C., Director | PPurchase | +4.36K | $18.31 | $79.9K | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-27 | Munsch Frederick SVP, Controller and CAO | FTax | −5.69K | $18.30 | $104K | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-27 | Munsch Frederick, SVP, Controller and CAO | FTax | −2.44K | $18.30 | $44.6K | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-27 | Stewart Andrew J. President, GPIC | FTax | −2.01K | $18.30 | $36.7K | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-27 | Bonnefoy Luc President, Surgical | FTax | −9.22K | $18.30 | $169K | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-27 | Bonnefoy Luc, President, Surgical | FTax | −4.31K | $18.30 | $78.9K | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-27 | Hashad Yehia EVP of R&D and CMO | FTax | −11.6K | $18.30 | $213K | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-27 | Hashad Yehia, EVP of R&D and CMO | FTax | −5.08K | $18.30 | $92.9K | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-27 | Bailey A Robert D EVP & Chief Legal Officer | FTax | −2.46K | $18.30 | $45.0K | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-27 | Eldessouky Sam EVP and CFO | FTax | −51.5K | $18.30 | $942K | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-27 | Eldessouky Sam, EVP and CFO | FTax | −15.5K | $18.30 | $284K | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-27 | SAUNDERS BRENT L CEO and Chairman of the Board | FTax | −24.6K | $18.30 | $451K | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-26 | Munsch Frederick SVP, Controller and CAO | FTax | −2.04K | $18.49 | $37.8K | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-26 | Stewart Andrew J. President, GPIC | FTax | −2.98K | $18.49 | $55.2K | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-26 | Bonnefoy Luc President, Surgical | FTax | −4.40K | $18.49 | $81.4K | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-26 | Hashad Yehia EVP of R&D and CMO | FTax | −2.17K | $18.49 | $40.1K | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-26 | Bailey A Robert D EVP & Chief Legal Officer | FTax | −3.40K | $18.49 | $62.8K | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-26 | Eldessouky Sam EVP and CFO | FTax | −7.06K | $18.49 | $131K | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-26 | SAUNDERS BRENT L CEO and Chairman of the Board | FTax | −22.1K | $18.49 | $408K | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-25 | Munsch Frederick SVP, Controller and CAO | AAward | +18.3K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-25 | Bonnefoy Luc President, Surgical | AAward | +30.4K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-25 | Stewart Andrew J. President, GPIC | AAward | +32.7K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-25 | Hashad Yehia EVP of R&D and CMO | AAward | +35.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-25 | Bailey A Robert D EVP & Chief Legal Officer | AAward | +52.6K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-25 | Eldessouky Sam EVP and CFO | AAward | +81.8K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-25 | SAUNDERS BRENT L CEO and Chairman of the Board | AAward | +327K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-25 | 2026-02-23 | SAUNDERS BRENT L CEO and Chairman of the Board | FTax | −65.4K | $17.99 | $1.18M | No | Form 4 ↗ |
| 2026-02-24 | 2026-02-23 | COLLIS STEVEN H Director | AAward | +4.49K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-24 | 2026-02-23 | COLLIS STEVEN H, Director | PPurchase | +15.0K | $17.81 | $267K | No | Form 4 ↗ |
| 2026-02-24 | 2026-02-20 | ROBERTSON RUSSEL C Director | AAward | +4.40K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-24 | 2026-02-20 | ROBERTSON RUSSEL C, Director | PPurchase | +4.40K | $17.90 | $78.8K | No | Form 4 ↗ |
| 2026-02-23 | 2026-02-19 | Ling Karen Director | AAward | +4.00K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-23 | 2026-02-19 | Ling Karen, Director | PPurchase | +4.00K | $17.74 | $71.0K | No | Form 4 ↗ |
| 2026-02-23 | 2026-02-19 | COLLIS STEVEN H Director | AAward | +5.25K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-23 | 2026-02-19 | Alfonso Eduardo Director | AAward | +5.25K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-23 | 2026-02-19 | ROBERTSON RUSSEL C Director | AAward | +1.45K | $17.65 | $25.6K | No | Form 4 ↗ |
| 2026-02-23 | 2026-02-19 | Paulson John Director | AAward | +1.24K | $17.65 | $21.9K | No | Form 4 ↗ |
| 2026-02-20 | 2026-02-18 | Munsch Frederick SVP, Controller and CAO | AAward | +12.5K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-20 | 2026-02-18 | Bonnefoy Luc President, Surgical | AAward | +10.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-20 | 2026-02-18 | Hashad Yehia EVP of R&D and CMO | AAward | +29.4K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-20 | 2026-02-18 | Eldessouky Sam EVP and CFO | AAward | +70.6K | $0.00 | $0.00 | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also BLCO’s full analysis or the market-wide insider trading feed. The tabs above jump to BLCO’s other SEC data.
Source: SEC Form 4 filings for BLCO, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.